Our previous studies demonstrated that DACT2 suppresses tumor proliferation by inhibiting canonical Wnt signaling in human hepatic, lung, thyroid and gastric cancers [20, 22, 23, 26]. This evidence concerns the gene DACT2 and gastric cancer.